2610301G19Rik Activators
2610301G19Rik Activators encompass a diverse group of chemical compounds that indirectly stimulate the functional activity of 2610301G19Rik through modulation of various cellular signaling pathways. Forskolin and IBMX elevate intracellular cAMP and cGMP levels, respectively, thereby enhancing protein kinase A (PKA) and other kinases' activities that could phosphorylate substrates within the same pathways as 2610301G19Rik, potentially leading to its activation. Similarly, PMA, as a protein kinase C (PKC) activator, and Sphingosine-1-phosphate, which is involved in sphingolipid signaling, may enhance overlapping pathways, thus indirectly augmenting 2610301G19Rik's function. Calcium signaling is another facet through which 2610301G19Rik activity could be enhanced, with compounds like Ionomycin and A23187 raising intracellular calcium levels and potentially activating calcium-dependent pathways that involve 2610301G19Rik.
Further, the functional activity of 2610301G19Rikis possibly enhanced through the inhibition of competitive signaling processes, as seen with the use of Epigallocatechin gallate (EGCG), a kinase inhibitor, and Genistein, a tyrosine kinase inhibitor. These inhibitors may reduce the competitive signaling within the pathways, potentially leading to an upsurge in 2610301G19Rik activity. Additionally, the PI3K inhibitor LY294002 and the MEK inhibitor U0126 might indirectly enhance 2610301G19Rik activity by altering upstream signaling, which could result in a compensatory increase in 2610301G19Rik's pathway involvement. Inhibition of p38 MAPK by SB203580 may shift the balance of signaling towards pathways that involve 2610301G19Rik, enhancing its activity. Lastly, Staurosporine, although a broad-spectrum protein kinase inhibitor, could paradoxically lead to the activation of 2610301G19Rik pathways by selectively lifting inhibition exerted by specific kinases, thus facilitating an increase in the functional activity of 2610301G19Rik without the need for upregulating its expression directly.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Non-specific inhibitor of phosphodiesterases, which increases intracellular cAMP and cGMP levels, potentially enhancing pathways where 2610301G19Rik is active by modulating kinase signaling. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Acts as a PKC activator, which can modulate signaling pathways that overlap with those involving 2610301G19Rik, leading to enhanced function of the protein. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Increases intracellular calcium levels, potentially enhancing calcium-dependent signaling pathways that 2610301G19Rik is part of, resulting in increased activity of the protein. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Through its role in sphingolipid signaling, it can enhance signaling pathways that 2610301G19Rik is involved in, possibly leading to increased activity of the protein. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A calcium ionophore that raises intracellular calcium levels, indirectly enhancing activation of 2610301G19Rik through calcium-dependent signaling pathways. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
A polyphenol that can act as a kinase inhibitor, potentially reducing competition within signaling pathways where 2610301G19Rik is active, thereby enhancing the protein's functional activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor that can alter signaling pathways upstream of 2610301G19Rik, potentially leading to increased activity of the protein through feedback mechanisms. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 MAPK, potentially augmenting signaling pathways that include 2610301G19Rik, thereby enhancing the protein's activity. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Inhibitor of tyrosine kinases, which can reduce competitive signaling and potentially enhance the activity of 2610301G19Rik within its specific pathways. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Non-specific protein kinase inhibitor that could lead to selective activation of pathways involving 2610301G19Rik by affecting regulatory kinases. | ||||||